Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares 10 20 Year Treasury Bond ETF (TLH) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

iShares 10 20 Year Treasury Bond ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares 10 20 Year Treasury Bond ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares 10 20 Year Treasury Bond ETF trades at $93.76 (market cap $11.47B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: iShares 10 20 Year Treasury Bond ETF is far larger — about 6.4× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares 10 20 Year Treasury Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares 10 20 Year Treasury Bond ETF for 62 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

TLHVIR
Market Cap
$11.47B$1.80B
Volume
2,063,9251,782,836
Sector
Fixed IncomeHealth
52-Week High
$105.36$11.78
52-Week Low
$91.34$5.12
Typical Hold Time
62 Days0 Days
Enterprise Value
—$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares 10 20 Year Treasury Bond ETF

TLH, the iShares 10-20 Year Treasury Bond ETF, trades at $92.56 with a slight 0.34% daily gain amid a challenging bond market environment. Technical indicators signal a bearish trend with selling pressure outweighing buying signals. Recent trading volume spikes indicate heightened investor interest as Treasury yields reach multi-decade highs, creating volatility for long-duration bond ETFs.

The outlook remains cautious as rising interest rates pressure bond prices, though the ETF provides exposure to US Treasury securities. Key risks include continued Fed tightening and inflation concerns, while potential stabilization in yields could offer support. Institutional activity shows mixed positioning with some funds reducing exposure.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TLH

No sentiment data available yet.

VIR
51% Buy49% Sell
Avg holding period · 0 Days

About iShares 10 20 Year Treasury Bond ETF

TLH tracks the ICE U.S. Treasury 10-20 Year Bond Index, offering targeted exposure to intermediate-to-long term government debt. It serves as a middle ground between the 7-10 year (IEF) and 20+ year (TLT) ETFs, balancing yield and duration risk.

Read more on TLH →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →